|
US4152411A
(en)
*
|
1977-07-27 |
1979-05-01 |
Akzona Incorporated |
High specific activity labeled substances
|
|
NZ191327A
(en)
*
|
1978-08-24 |
1981-07-13 |
W B Martin |
Pasteurellosis vaccine comprising antigenic material derived from the a1 and a2 serotypes of pasteurella haemolytica
|
|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US4837151A
(en)
*
|
1980-05-19 |
1989-06-06 |
The Board Of Trustees Of The Leland Stanford Junior University, Stanford University |
Live vaccines comprising two mutations and foreign antigen
|
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4554101A
(en)
*
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US5097020A
(en)
*
|
1983-07-05 |
1992-03-17 |
The University Of Rochester |
Immunogenic conjugates
|
|
US5360897A
(en)
*
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
|
US4673574A
(en)
*
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
US4902506A
(en)
*
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
|
US4454121A
(en)
*
|
1982-07-27 |
1984-06-12 |
The University Of Tennessee Research Corporation |
Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4650764A
(en)
*
|
1983-04-12 |
1987-03-17 |
Wisconsin Alumni Research Foundation |
Helper cell
|
|
US4784948A
(en)
*
|
1983-08-10 |
1988-11-15 |
The Rockefeller University |
Production of streptococcal m protein immunogens and molecular probes
|
|
US4695562A
(en)
*
|
1984-04-06 |
1987-09-22 |
Univ. Of Tennessee Research Corp. |
Synthetic peptide compounds
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
GB8424757D0
(en)
|
1984-10-01 |
1984-11-07 |
Pasteur Institut |
Retroviral vector
|
|
US4720489A
(en)
|
1984-10-15 |
1988-01-19 |
Douglas Shander |
Hair growth modification with ornithine decarboxylase inhibitors
|
|
FR2573436B1
(fr)
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US5168062A
(en)
*
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4797368A
(en)
*
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4666829A
(en)
*
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
|
US5078996A
(en)
*
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
|
US5139941A
(en)
*
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4772584A
(en)
*
|
1986-05-23 |
1988-09-20 |
Cleary Paul P |
Inhibitor of C5a-mediated chemotaxis
|
|
IT1216262B
(it)
*
|
1986-09-02 |
1990-02-22 |
Bargellini Andrea |
Assorbente,ed utensile cosi'procedimento ed attrezzatura per la realizzato. formazione di un utensile di pulizia a strisce di materiale
|
|
EP0272929B1
(en)
|
1986-12-24 |
1996-03-20 |
Genentech, Inc. |
Enkephalinase for therapeutic use
|
|
US5057540A
(en)
*
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5124153A
(en)
*
|
1987-08-24 |
1992-06-23 |
University Of Tennessee Research Corp. |
Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
|
|
US5162226A
(en)
*
|
1987-08-24 |
1992-11-10 |
University Of Tennessee Research Corp. (U.T.R.C.) |
Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
|
|
WO1989007150A1
(en)
|
1988-02-05 |
1989-08-10 |
The Trustees Of Columbia University In The City Of |
Retroviral packaging cell lines and processes of using same
|
|
EP0365646B1
(en)
|
1988-03-25 |
1996-05-08 |
The Rockefeller University |
Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
|
|
US4912094B1
(en)
*
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
CA1339354C
(en)
|
1988-09-01 |
1997-08-26 |
The Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
JP2871709B2
(ja)
|
1988-11-21 |
1999-03-17 |
住友製薬株式会社 |
免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法
|
|
US5354844A
(en)
|
1989-03-16 |
1994-10-11 |
Boehringer Ingelheim International Gmbh |
Protein-polycation conjugates
|
|
US5703055A
(en)
*
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5399346A
(en)
*
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
|
US5264618A
(en)
*
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
SE9002212D0
(sv)
|
1990-06-21 |
1990-06-21 |
Hightech Receptor Ab |
Igg binding protein
|
|
WO1992002612A2
(en)
|
1990-07-31 |
1992-02-20 |
Genentech, Inc. |
Tissue plasminogen activator variants with decreased clearance
|
|
ES2150416T3
(es)
|
1990-09-25 |
2000-12-01 |
Cantab Pharma Res |
Vacuna virica defectiva producida por una linea celular complementada en trans.
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
|
US6100380A
(en)
*
|
1991-10-28 |
2000-08-08 |
Cytran, Inc. |
Immunomodulating peptides and methods of use
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
EP0672123A1
(en)
|
1992-01-08 |
1995-09-20 |
The Rockefeller University |
Multifunctional surface protein of streptococci
|
|
NZ251096A
(en)
|
1992-03-09 |
1996-03-26 |
Univ California |
Sialyltransferases and compositions and methods for their identification and synthesis
|
|
WO1993021220A1
(en)
|
1992-04-08 |
1993-10-28 |
The Council Of The Queensland Institute Of Medical Research |
Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
|
|
CA2123579C
(en)
|
1992-09-16 |
2005-05-10 |
James B. Dale |
Recombinant multivalent m protein vaccine
|
|
IL107026A0
(en)
|
1992-09-16 |
1993-12-28 |
Univ Tennessee Res Corp |
Antigen of hybrid m protein and carrier for group a streptococcal vaccine
|
|
WO1994012649A2
(en)
|
1992-12-03 |
1994-06-09 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US5593972A
(en)
*
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
JPH08507784A
(ja)
|
1993-03-19 |
1996-08-20 |
キャンタブ ファーマシューティカルズ リサーチ リミティド |
ウイルス・ワクチン
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
RU2219241C2
(ru)
|
1993-07-13 |
2003-12-20 |
Рон-Пуленк Роре С.А. |
Дефектный рекомбинантный аденовирусный вектор (варианты)
|
|
AU7477394A
(en)
|
1993-07-30 |
1995-03-27 |
University Of Medicine And Dentistry Of New Jersey |
Efficient gene transfer into primary lymphocytes
|
|
FR2714830B1
(fr)
|
1994-01-10 |
1996-03-22 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
|
FR2715847B1
(fr)
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
|
FR2716459B1
(fr)
|
1994-02-22 |
1996-05-10 |
Univ Paris Curie |
Système hôte-vecteur utilisable en thérapie génique.
|
|
AU2194895A
(en)
|
1994-03-25 |
1995-10-17 |
Uab Research Foundation, The |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
|
WO1995028494A1
(en)
|
1994-04-15 |
1995-10-26 |
Targeted Genetics Corporation |
Gene delivery fusion proteins
|
|
US5571515A
(en)
*
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
|
US5866135A
(en)
|
1994-04-21 |
1999-02-02 |
North American Vaccine, Inc. |
Group A streptococcal polysaccharide immunogenic compositions and methods
|
|
US5505947A
(en)
*
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5679654A
(en)
*
|
1994-09-02 |
1997-10-21 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
|
US5837533A
(en)
*
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
|
FR2727679B1
(fr)
|
1994-12-05 |
1997-01-03 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
|
US7153510B1
(en)
*
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
AU6043396A
(en)
|
1995-06-05 |
1996-12-24 |
University Of Alabama At Birmingham Research Foundation, The |
Composition and methods for creating syngeneic recombinant v irus-producing cells
|
|
FR2741358B1
(fr)
|
1995-11-17 |
1998-01-02 |
Centre Nat Rech Scient |
Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn
|
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
US6355255B1
(en)
*
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
US5829302A
(en)
*
|
1996-05-31 |
1998-11-03 |
The National Machinery Company |
Cassette tooling
|
|
IT1289387B1
(it)
|
1996-07-16 |
1998-10-02 |
Zanussi Elettromecc |
Perfezionamenti ai circuiti refrigeranti a compressione per apparecchi domestici e simili
|
|
CA2265554A1
(en)
|
1996-09-27 |
1998-04-02 |
American Cyanamid Company |
3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
|
|
US6113918A
(en)
*
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
BR9810500A
(pt)
|
1997-06-30 |
2000-09-05 |
Rhone Poulenc Rorer Sa |
Sistema e aparelho para a transferência de ácido nucléico in vivo para o interior de células de organismos eucarióticos pluricelulares
|
|
JP4664450B2
(ja)
|
1997-06-30 |
2011-04-06 |
アンステイテユ・ギユスタブ・ルシー |
多細胞化真核生物細胞に核酸を導入する改良法およびその組合せ
|
|
CZ299473B6
(cs)
|
1997-06-30 |
2008-08-06 |
Rhone-Poulenc Rorer S. A. |
Nukleová kyselina a elektrické pole jako sdruženýprodukt pro prenos nukleové kyseliny do bunek prícne pruhovaného svalstva
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
MXPA01003228A
(es)
|
1998-09-30 |
2003-06-24 |
American Cyanamid Co |
Holotoxina de colera mutante como un coadyuvante.
|
|
US6168911B1
(en)
*
|
1998-12-18 |
2001-01-02 |
Eastman Kodak Company |
Formulations for preparing metal oxide-based pigment-binder transparent electrically conductive layers
|
|
WO2000037648A1
(en)
|
1998-12-22 |
2000-06-29 |
The University Of Tennessee Research Corporation |
Protective antigen of group a streptococci (spa)
|
|
EP1075841A1
(en)
|
1999-08-13 |
2001-02-14 |
Erasmus Universiteit Rotterdam |
Pneumococcal vaccines
|
|
US7256265B2
(en)
*
|
1999-12-03 |
2007-08-14 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
EP1328543B1
(en)
*
|
2000-10-27 |
2009-08-12 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
AU2002306849A1
(en)
|
2001-03-21 |
2002-10-08 |
Elitra Pharmaceuticals, Inc. |
Identification of essential genes in microorganisms
|
|
JP2004533236A
(ja)
|
2001-04-13 |
2004-11-04 |
ワイエス |
化膿性連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｙｏｇｅｎｅｓ）の表面タンパク質
|
|
WO2004078907A2
(en)
*
|
2003-03-04 |
2004-09-16 |
Intercell Ag |
Streptococcus pyogenes antigens
|
|
CN100579985C
(zh)
*
|
2003-05-07 |
2010-01-13 |
英特塞尔股份公司 |
无乳链球菌抗原ⅰ和ⅱ
|
|
PL1648500T3
(pl)
*
|
2003-07-31 |
2014-12-31 |
Novartis Vaccines & Diagnostics Inc |
Kompozycje immunogenne dla Streptococcus pyogenes
|
|
RU2263143C2
(ru)
*
|
2004-01-05 |
2005-10-27 |
ГНУ Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева |
Штамм бактерий streptococcus pyogenes №289, используемый для изготовления вакцин против стрептококкоза пушных зверей
|
|
EP1721283B1
(en)
|
2004-02-06 |
2022-11-30 |
Council of Scientific and Industrial Research |
Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
|
|
EP1762568A1
(en)
*
|
2004-07-01 |
2007-03-14 |
Daiichi Pharmaceutical Co., Ltd. |
Pyrazole derivatives
|
|
SG10201606278UA
(en)
*
|
2004-08-18 |
2016-09-29 |
Novabiotics Ltd |
Peptide
|
|
JP2008544949A
(ja)
*
|
2004-10-08 |
2008-12-11 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
化膿性レンサ球菌のための免疫激性組成物および治療用組成物
|
|
EP1838317A4
(en)
|
2005-01-05 |
2012-02-29 |
Univ Minnesota |
ANALGESIC CONJUGATES
|
|
WO2007035823A2
(en)
|
2005-09-20 |
2007-03-29 |
Molecular Neuroimaging, Llc |
Partial mglur5 antagonists and methods of use thereof
|
|
CN102316894A
(zh)
*
|
2008-06-20 |
2012-01-11 |
惠氏有限责任公司 |
来自β-溶血性链球菌菌株的ORF1358的组合物和使用方法
|
|
WO2009155476A2
(en)
*
|
2008-06-20 |
2009-12-23 |
Wyeth |
Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
|
|
CN102203122A
(zh)
*
|
2008-11-05 |
2011-09-28 |
惠氏有限责任公司 |
用于预防β-溶血链球菌(BHS)疾病的多组分免疫原性组合物
|